Validity of the Ages and Stages Questionnaire to identify young children with gross motor difficulties who require physiotherapy assessment

John R Fauls, Bronwyn L Thompson, Leanne M Johnston, John R Fauls, Bronwyn L Thompson, Leanne M Johnston

Abstract

Aim: To determine if the Ages and Stages Questionnaire, Third Edition Gross Motor domain (ASQ-3-GM) score is predictive of motor performance on the Alberta Infant Motor Scale (AIMS) and/or Neurological, Sensory, Motor, Developmental Assessment (NSMDA).

Method: This was a cross-sectional study involving analysis of a 1-year consecutive clinical sample of data obtained from children attending a specialist public outpatient service. Participants were 84 children aged 0 to 5 years (mean age 24.9mo, SD 18.4mo; 50 males, 34 females) referred for physiotherapy assessment of gross motor skills in a tertiary child development service. Parents completed the ASQ-3 questionnaire and children were assessed using the AIMS (if aged 0-18mo) and/or NSMDA (all children). To determine possible relationships between ASQ-3-GM scores with AIMS and NSMDA scores, we calculated Spearman's rank correlation coefficients. To determine validity of the ASQ-3-GM 'refer for further assessment' ('refer') cut-off score to identify gross motor difficulties we calculated frequency distributions and crosstab analyses.

Results: ASQ-3-GM scores correlated with AIMS centile rank (r=0.697, p<0.001) and NSMDA motor performance classification (r=-0.548, p<0.001). The ASQ-3-GM 'refer' cut-off had 77% sensitivity, 91% specificity, and 95% positive predictive value (PPV) to identify children that scored ≤10th centile on the AIMS and 57% sensitivity, 92% specificity, and 97% PPV to identify children with at least minimal dysfunction on the NSMDA.

Interpretation: The ASQ-3-GM 'refer' cut-off score is a valid predictor of gross motor difficulties in young children.

What this paper adds: The Ages and Stages Questionnaire, Third Edition Gross Motor domain (ASQ-3-GM) score is valid to identify gross motor difficulties in young children. The ASQ-3-GM 'refer' cut-off had 95% positive predictive value (PPV) for children that scored ≤10th centile on the Alberta Infant Motor Scale. The ASQ-3-GM 'refer' cut-off had 97% PPV for at least minimal dysfunction on the Neurological, Sensory, Motor, Developmental Assessment.

© 2020 Mac Keith Press.

References

REFERENCES

    1. Piper MC, Darrah J. Motor assessment of the developing infant. Philadelphia: Saunders, 1994.
    1. Zwicker JG, Missiuna C, Harris SR, Boyd LA. Developmental coordination disorder: a review and update. Eur J Paediatr Neurol 2012; 16: 573-81.
    1. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol 2013; 55: 509-19.
    1. Randall M, Sciberras E, Brignell A, et al. Autism spectrum disorder: presentation and prevalence in a nationally representative Australian sample. Aust N Z J Psychiatry 2016; 50: 243-53.
    1. Mithyantha R, Kneen R, McCann E, Gladstone M. Current evidence-based recommendations on investigating children with global developmental delay. Arch Dis Child 2017; 102: 1071-6.
    1. Blank R, Smits-Engelsman B, Polatajko H, Wilson P. European Academy for Childhood Disability (EACD): recommendations on the definition, diagnosis and intervention of developmental coordination disorder (long version). Dev Med Child Neurol 2011; 54: 54-93.
    1. Van der Linde BW, van Netten JJ, Otten B, Postema K, Geuze RH, Schoemaker MM. Activities of daily living in children with developmental coordination disorder: performance, learning, and participation. Phys Ther 2015; 95: 1496-506.
    1. Asonitou K, Koutsouki D, Kourtessis T, Charitou S. Motor and cognitive performance differences between children with and without developmental coordination disorder (DCD). Res Dev Disabil 2012; 33: 996-1005.
    1. Leung GP, Chan CC, Chung RC, Pang MY. Determinants of activity and participation in preschoolers with developmental delay. Res Dev Disabil 2011; 32: 289-96.
    1. Spittle A, Orton J, Anderson PJ, Boyd R, Doyle LW. Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants. Cochrane Database Syst Rev 2015; (11): CD005495.
    1. Duby J, Lipkin P, Macias M, Wegner L. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006; 118: 405-20.
    1. Spittle AJ, Lee KJ, Spencer-Smith M, Lorefice LE, Anderson PJ, Doyle LW. Accuracy of two motor assessments during the first year of life in preterm infants for predicting motor outcome at preschool age. PLoS One 2015; 10: e0125854.
    1. Spittle AJ, Doyle LW, Boyd RN. A systematic review of the clinimetric properties of neuromotor assessments for preterm infants during the first year of life. Dev Med Child Neurol 2008; 50: 254-66.
    1. Darrah J, Bartlett D, Maguire TO, Avison WR, Lacaze-Masmonteil T. Have infant gross motor abilities changed in 20 years? A re-evaluation of the Alberta Infant Motor Scale normative values. Dev Med Child Neurol 2014; 56: 877-81.
    1. Darrah J, Piper M, Watt MJ. Assessment of gross motor skills of at-risk infants: predictive validity of the Alberta Infant Motor Scale. Dev Med Child Neurol 1998; 40: 485-91.
    1. Burns Y, Ensbey RM, Norrie MA. The neuro-sensory motor developmental assessment part II: predictive and concurrent validity. J Physiother 1989; 35: 151-7.
    1. Danks M, Maideen MF, Burns Y, et al. The long-term predictive validity of early motor development in ‘apparently normal’ ELBW survivors. Early Hum Dev 2012; 88: 637-41.
    1. Wilson BN, Crawford SG, Green D, Roberts G, Aylott A, Kaplan BJ. Psychometric properties of the revised developmental coordination disorder questionnaire. Phys Occup Ther Pediatr 2009; 29: 182-202.
    1. Noeder MM, Logan BA, Struemph KL, et al. Developmental screening in children with CHD: ages and stages questionnaires. Cardiol Young 2017; 27: 1447-54.
    1. Agarwal PK, Shi L, Daniel LM, et al. Prospective evaluation of the Ages and Stages Questionnaire 3rd Edition in very-low-birthweight infants. Dev Med Child Neurol 2017; 59: 484-9.
    1. Squires J, Twombly E, Bricker D, Potter L. Ages and Stages Questionnaires (3rd edition): User’s Guide. Baltimore, MD: Paul H. Brookes Publishing Co., 2009.
    1. King-Dowling S, Rodriguez MC, Missiuna C, Cairney J. Validity of the Ages and Stages Questionnaire to detect risk of developmental coordination disorder in preschoolers. Child Care Health Dev 2016; 42: 188-94.
    1. Veldhuizen S, Clinton J, Rodriguez C, Wade TJ, Cairney J. Concurrent validity of the Ages and Stages Questionnaires and Bayley Developmental Scales in a general population sample. Acad Pediatr 2015; 15: 231-7.
    1. Ga HY, Kwon JY. A comparison of the Korean ages and stages questionnaires and Denver developmental delay screening test. Ann Phys Rehabil Med 2011; 35: 369-74.
    1. Skellern C, Rogers Y, O’Callaghan M. A parent-completed developmental questionnaire: follow up of ex-premature infants. J Paediatr Child Health 2001; 37: 125-9.
    1. San Antonio CM, Fenick MA, Shabanova MV, Leventhal CJ, Weitzman CC. Developmental screening using the Ages and Stages Questionnaire: standardized versus real-world conditions. Infants Young Child 2014; 27: 111-9.
    1. Burns Y. Physiotherapy assessment for infants and young children (2nd edition). Brisbane: CopyRight Publishing Company Pty Ltd, 2014.
    1. Burns Y, Ensbey RM, Norrie MA. The neuro-sensory motor developmental assessment part 1: Development and administration of the test. J Physiother 1989; 35: 141-9.
    1. MacDonald J, Burns Y. Performance on the NSMDA during the first and second year of life to predict functional ability at the age of 4 in children with cerebral palsy. Hong Kong Physiother J 2005; 23: 40-5.
    1. Schober AP, Boer AC, Schwarte AL. Correlation coefficients: appropriate use and interpretation. Anesth Analg 2018; 126: 1763-8.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj